Status:
RECRUITING
Application of QDSA Platform in Cerebrovascular Diseases
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Cerebrovascular Disease
Eligibility:
All Genders
1-80 years
Brief Summary
Cerebrovascular diseases pose a major global public health challenge, characterized by exceptionally high mortality and disability rates, with their pathogenesis closely linked to hemodynamic abnormal...
Detailed Description
Study overview: This study will construct a prospective cohort dataset that comprehensively integrates DSA features, clinical baseline data, clinical manifestations, and follow-up data. Using QDSA tec...
Eligibility Criteria
Inclusion
- Cerebrovascular diseases diagnosed and assessed by DSA for related risks and treatment options.
- The DSA acquisition protocol complies with the standard procedure.
- DSA images must include complete anteroposterior and lateral views.
- Raw data must be available in DICOM format.
- Image quality and pixel resolution must support data analysis.
- Patients must undergo regular follow-ups.
Exclusion
- Cerebrovascular diseases not diagnosed or risk-assessed using DSA.
- Patients with DSA image quality insufficient for image analysis and processing.
- Severe organ diseases with an expected survival period of less than 2 years.
- Inability to cooperate with treatment and follow-up.
- Participation in other clinical trials within the past 6 months.
- Other conditions deemed by the investigator as unsuitable for participation in this trial.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06902415
Start Date
April 1 2025
End Date
February 1 2030
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070